Matches in Wikidata for { <http://www.wikidata.org/entity/Q60685461> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q60685461 description "articolo scientifico (pubblicato il 1997)" @default.
- Q60685461 description "artikull shkencor i botuar më 01 janar 1997" @default.
- Q60685461 description "artículu científicu espublizáu en xineru de 1997" @default.
- Q60685461 description "im Januar 1997 veröffentlichter wissenschaftlicher Artikel" @default.
- Q60685461 description "scientific article published on 01 January 1997" @default.
- Q60685461 description "wetenschappelijk artikel" @default.
- Q60685461 description "наукова стаття, опублікована в 1997" @default.
- Q60685461 name "Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymph" @default.
- Q60685461 name "Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymph" @default.
- Q60685461 name "Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymph" @default.
- Q60685461 type Item @default.
- Q60685461 label "Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymph" @default.
- Q60685461 label "Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymph" @default.
- Q60685461 label "Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymph" @default.
- Q60685461 prefLabel "Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymph" @default.
- Q60685461 prefLabel "Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymph" @default.
- Q60685461 prefLabel "Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymph" @default.
- Q60685461 P1433 Q60685461-2FF0C150-3E73-40B1-AD63-47A9F8E26C3A @default.
- Q60685461 P1476 Q60685461-315B5B90-56D5-4ACB-A509-0A29226E6DF0 @default.
- Q60685461 P2093 Q60685461-0DDA6668-12F2-4936-8DA7-FA66A7F34424 @default.
- Q60685461 P2093 Q60685461-18B63B25-1136-4170-84CF-B75BD33A59DD @default.
- Q60685461 P2093 Q60685461-2A99893D-751C-4289-9D05-C349072D7253 @default.
- Q60685461 P2093 Q60685461-4639A3B6-C8D5-4FC6-B660-56FA2F7521EB @default.
- Q60685461 P2093 Q60685461-4A7F5821-8DE2-41C9-AC83-E41B4C8490FD @default.
- Q60685461 P2093 Q60685461-98CE0A7E-AF32-4F73-94DE-C93898DB56BF @default.
- Q60685461 P2093 Q60685461-9C8274F7-E9B7-4078-AA7A-F8B6EC065265 @default.
- Q60685461 P2093 Q60685461-9F9AFAC9-A437-49CE-B061-F2E59A8F7C68 @default.
- Q60685461 P2093 Q60685461-D4CD5870-94D0-4C85-A9FE-061980601D11 @default.
- Q60685461 P2093 Q60685461-DE0BA1A7-AF93-4892-A60F-71E15D074DFE @default.
- Q60685461 P2093 Q60685461-F4B6CE27-2818-4BC1-9166-2059A68B65A5 @default.
- Q60685461 P304 Q60685461-F7C93266-94B9-4A67-B6B3-0A31BA379562 @default.
- Q60685461 P31 Q60685461-586FB956-EBB5-4C7D-82BD-6F2485AC5A21 @default.
- Q60685461 P356 Q60685461-A6569613-B338-4138-B25C-9499C355A7E8 @default.
- Q60685461 P433 Q60685461-57FCBC62-35C7-4AAB-8233-97540919FEFD @default.
- Q60685461 P478 Q60685461-A0A97104-711C-4C20-99DC-08AAC10F31D8 @default.
- Q60685461 P50 Q60685461-4980CF3D-4F81-4D9E-B97F-1F037C0306AD @default.
- Q60685461 P50 Q60685461-7EB188E2-6B40-47DE-BCFE-40C40A113F87 @default.
- Q60685461 P577 Q60685461-F7C8A81B-ACE5-4E6E-B5BE-7A7A848E9951 @default.
- Q60685461 P698 Q60685461-14135504-475E-48CE-90C5-191E895C62A8 @default.
- Q60685461 P921 Q60685461-CEDB0F83-9E39-4FC1-BB44-618DD38733EE @default.
- Q60685461 P356 A:1008286824606 @default.
- Q60685461 P698 9187443 @default.
- Q60685461 P1433 Q326122 @default.
- Q60685461 P1476 "Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie" @default.
- Q60685461 P2093 "A Hagenbeek" @default.
- Q60685461 P2093 "A Mandard" @default.
- Q60685461 P2093 "A Pinna" @default.
- Q60685461 P2093 "A van Hoof" @default.
- Q60685461 P2093 "E Noordijk" @default.
- Q60685461 P2093 "J Raemaekers" @default.
- Q60685461 P2093 "J Thomas" @default.
- Q60685461 P2093 "M Burgers" @default.
- Q60685461 P2093 "M Vovk" @default.
- Q60685461 P2093 "P Carde" @default.
- Q60685461 P2093 "W Breed" @default.
- Q60685461 P304 "111-114" @default.
- Q60685461 P31 Q13442814 @default.
- Q60685461 P356 "10.1023/A:1008286824606" @default.
- Q60685461 P433 "1+" @default.
- Q60685461 P478 "8 Suppl 1" @default.
- Q60685461 P50 Q45894648 @default.
- Q60685461 P50 Q56942857 @default.
- Q60685461 P577 "1997-01-01T00:00:00Z" @default.
- Q60685461 P698 "9187443" @default.
- Q60685461 P921 Q42824827 @default.